- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: patients with multiple myeloma
Total 200563 results
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.Completed
-
AstraZenecaTerminatedLymphoma | Multiple Myeloma | Advanced Solid Tumors | Hematologic MalignanciesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Active, not recruitingAcute Myeloid Leukemia | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Plasma Cell Myeloma | Aplastic Anemia | Malignant Neoplasm | Myeloproliferative Neoplasm | Indolent Non-Hodgkin Lymphoma | Acute Myeloid Leukemia in Remission | Refractory Anemia | Refractory Anemia With... and other conditionsUnited States
-
Second Affiliated Hospital of Wenzhou Medical UniversityCompleted
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Zhongnan HospitalCompleted
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
iOMEDICO AGAmgenActive, not recruiting
-
Institut CurieCelgene Corporation; Intergroupe Francophone du MyelomeCompleted
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
Catalina CodreanuCompletedMultiple Myeloma | Venous Thromboembolism | Arterial ThromboembolismNetherlands
-
Fondazione EMN Italy OnlusCompleted
-
Regeneron PharmaceuticalsAvailable
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditionsUnited States
-
Abramson Cancer Center at Penn MedicineCompletedMultiple MyelomaUnited States
-
Beth Israel Deaconess Medical CenterMassachusetts General Hospital; Rambam Health Care Campus; Dana-Farber Cancer... and other collaboratorsCompletedMultiple MyelomaUnited States, Israel
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Lava TherapeuticsActive, not recruitingAcute Myeloid Leukemia | Multiple Myeloma | Chronic Lymphocytic LeukemiaUnited States, Spain, France, Netherlands
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteTerminatedMultiple MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
zr Pharma & GmbHCompletedMultiple MyelomaUnited States
-
Boryung Pharmaceutical Co., LtdCompletedMultiple MyelomaKorea, Republic of
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
Roswell Park Cancer InstituteActive, not recruitingHodgkin Lymphoma | Waldenstrom Macroglobulinemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Myeloproliferative Neoplasm | Minimal Residual Disease | Graft Versus Host Disease | Severe Aplastic Anemia | Acute Myeloid Leukemia in Remission | Adult Acute Lymphoblastic Leukemia... and other conditionsUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingLymphoma, Non-Hodgkin | B-cell Lymphoma | Multiple Myeloma | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Leukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, B-cell Marginal ZoneUnited States, France, Poland, Italy
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
Nantes University HospitalActive, not recruitingMultiple Myeloma at First RelapseFrance
-
Fondazione EMN Italy OnlusCompleted
-
Nantes University HospitalTerminatedMultiple Myeloma in Older PatientsFrance
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
University of Heidelberg Medical CenterActive, not recruiting
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la LoireCompletedMultiple Myeloma | Renal FailureFrance, Belgium, Algeria, Lebanon
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)SuspendedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Oslo University HospitalNordic Myeloma Study GroupActive, not recruitingMyelomaNorway, Denmark, Sweden
-
Emory UniversityNational Cancer Institute (NCI); Takeda; National Institutes of Health (NIH); Janssen...Active, not recruiting
-
Barbara Ann Karmanos Cancer InstituteCompletedChronic Lymphocytic Leukemia | Plasma Cell Myeloma | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Medical College of WisconsinGenzyme, a Sanofi CompanyCompletedMultiple Myeloma | Bone Marrow Transplant ComplicationsUnited States
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaCanada, United States, Israel, Czechia, Switzerland, Greece, Denmark, Portugal, Italy, Germany, Austria, Norway, Puerto Rico, Spain, Sweden, Turkey
-
University of UtahCantex PharmaceuticalsTerminatedMultiple MyelomaUnited States
-
Oncopeptides ABTerminatedMultiple Myeloma | Renal ImpairmentGreece, Czechia, Poland
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Cellectar Biosciences, Inc.CompletedMultiple MyelomaUnited States